Business

Edward Gilbert, Wall Street celebrity turned felon, has found new fortune selling real estate partnerships. He proves that genius is leverage in a rising market.

Has bringing down the law on music pirates backfired on the record industry?

Money advice is universal, but some issues affect women more than men. Experts also say women tend to be less knowledgeable and confident about finances.

If your crucial joints are still intact, or just beginning to creak, here are some ways to keep osteoarthritis — and the cost of hip or knee replacement — at bay.

Cutting small expenses can make consumers feel good, but people who are living far beyond their means need to make major financial changes.

A new model for socially responsible investing is allowing high net worth investors to do good and make a profit.

Readers comments from this week's Your Money column, which discusses how women fare when it comes to money matters.

It isn’t philanthropy and it isn’t socially responsible investing. Think of it as a private equity fund for social change.

Instead of scrambling at the end of the year to make donations, consider setting up automated giving throughout the year.

Here are some resources to help you turn your tax return into a financial report card.

Help with the the buy or rent decision, free hot spots for some cable customers and other consumer-focused items from Friday's Times.

Here's how to quickly find out if there is any unclaimed property you're entitled to.

Customers' satisfaction with their banks continues to drop and they appear more willing to switch banks than in the past, according to a study released Thursday by J.D. Power and Associates.

How to tell if the housing market is coming back.

Cash prizes from marketers, JetBlue and Hilton team up and other consumer-focused items from Thursday's Times.

Investors have awakened to growth in the Boeing food chain. There's still room to go for 787-related companies.

TVs that connect to the Web are evolving. Here are tips that can help you figure out what you need.

The real arguments and the phonies.

Price targets are the key to locking in long-term returns.

These companies are developing treatments that could have significant effects on medical practice.